Executive Profile

Brenda D. Gavin D.V.M., M.B.A. Managing Partner and Founding Partner, Quaker BioVentures

Age	Total Calculated Compensation	This person is connected to 8 Board Members in 8 different organizations across 13 different industries. See Board Relationships
64	--

Background

Dr. Brenda D. Gavin, D.V.M., M.B.A. is a Managing Partner and Founding Partner at Quaker BioVentures. Previously, Dr. Gavin was the President at S.R. One Limited, where she was responsible for direct venture and strategic investments. Prior to joining S.R. One in 1989, Dr. Gavin was the Director of Business Development at SmithKline Beecham Animal Health Products. She has also served as a General Partner at EuclidSR Partners. Dr. Gavin started her career as an epidemiologist ... at the Centers for Disease Control and Prevention. She is a Director of BioAdvance. Dr. Gavin earlier served as the Vice Chairman of BioAdvance. She serves as a Board Member of Bioleap, Eximias Pharmaceutical Corporation, TetraLogic Pharmaceuticals, Inc., Innovation Philadelphia, and Diasome Pharmaceuticals, LLC. She is an active Board Observer of Nucleonics Inc. He served as a Director of Celator Pharmaceuticals, Inc until August 2012. Dr. Gavin served as a Director of Tranzyme, Inc. until September 20, 2011. Dr. Gavin served as a Board Member or active Board Observer for many of S.R. One’s portfolio companies including Adolor, Inhale, Sepracor, Diasome Pharmaceuticals, and Versicor. She served on the board of Tengion, Inc. until August 10, 2011. She also served on the board of MicroMass Communications, Oxis International, and Synbiotics. Dr. Gavin currently serves on the International Advisory Board of Pennsylvania State University Research Foundation and the Monell Institute and is a Director of Ben Franklin Technology Development Authority, the Pennsylvania State University Research Foundation, and Innovation Philadelphia. She also serves as a Board Member and Secretary of Ben Franklin Technology Center of Southeastern Pennsylvania. She was also the Chairman of the Greater Philadelphia Venture Group. Dr. Gavin served as a Director at National Venture Capital Association. Dr. Gavin received an M.B.A. from the University of Texas, San Antonio, Doctor of Veterinary Medicine magna cum laude from the University of Missouri and a B.S. from Baylor University.

Corporate Headquarters 2929 Arch Street Philadelphia, Pennsylvania 19104-2868 United States Phone: 215-988-6800 Fax: 215-988-6801 Board Members Memberships Secretary and Director Ben Franklin Technology Partners of Southeastern Pennsylvania, Investment Arm Former Director Amerifit Brands, Inc. Director Message Pharmaceuticals Inc. Former Director MicroMass Communications Inc. Former Director Therion Biologics Corporation Chairman of the Board YM BioSciences USA Inc. Former Director Celator Pharmaceuticals, Inc. Director Innovation Philadelphia Inc. Director National Venture Capital Association Director BioAdvance Director TetraLogic Pharmaceuticals, Inc. Director Diasome Pharmaceuticals, Inc. Director BioLeap, LLC 2005-2011 Former Director and Member of Nominating & Corporate Governance Committee Tranzyme, Inc. 2006-2011 Former Director and Member of Governance & Nominating Committee Tengion, Inc. Education BS Baylor University MBA University Of Texas At San Antonio Doctorate University of Missouri-Columbia Other Affiliations Ben Franklin Technology Partners of Southeastern Pennsylvania, Investment Arm EuclidSR Partners SR One Amerifit Brands, Inc. Message Pharmaceuticals Inc. MicroMass Communications Inc. Therion Biologics Corporation YM BioSciences USA Inc. SmithKline Beecham Limited Synbiotics Corporation Celator Pharmaceuticals, Inc. Tranzyme, Inc. EuclidSR Partners, L.P. Quaker BioVentures Fund I, L.P. Innovation Philadelphia Inc. Baylor University University of Missouri-Columbia University Of Texas At San Antonio Independence Capital Partners National Venture Capital Association BioAdvance Tengion, Inc. TetraLogic Pharmaceuticals, Inc. Garden State Life Sciences Venture Fund L.P. BioAdvance Ventures, L.P. Diasome Pharmaceuticals, Inc. Quaker BioVentures Fund II, L.P. BioLeap, LLC

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.